U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07191366) titled 'Antenatal Breastmilk Expression in Pregnant Women at High Risk of Preterm Birth' on Sept. 01.
Brief Summary: In this randomized controlled study, the investigators aim to examine if antenatal breastmilk expression (aBME) from week 28 in high-risk pregnancies is a safe and effective method to ensure early access to mother's own milk.
In addition, this study will analyze and compare colostrum from pregnancy with colostrum after birth, investigates women's confidence in breastfeeding and breastfeeding establishment as well as measures oxytocin levels during aBME and active labour with no aBME.
Study Start Date: Sept., 2026
Study Ty...